NDC 73462-101

Cosela

Trilaciclib

Cosela is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by G1 Therapeutics, Inc.. The primary component is Trilaciclib Dihydrochloride.

• Product ID: 73462-101_adbbba9b-6d72-49e3-8bcf-5cee09278b08
• NDC: 73462-101
• Product Type: Human Prescription Drug
• Proprietary Name: Cosela
• Generic Name: Trilaciclib
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-02-12
• Marketing Category: NDA /
• Application Number: NDA214200
• Labeler Name: G1 Therapeutics, Inc.
• Substance Name: TRILACICLIB DIHYDROCHLORIDE
• Active Ingredient Strength: 300 mg/20mL
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 73462-101-01

1 VIAL, GLASS in 1 CARTON (73462-101-01) > 20 mL in 1 VIAL, GLASS

• Marketing Start Date: 2021-02-12
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details